Gradient Investments’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.58M | Sell |
3,160
-14
| -0.4% | -$6.72K | 0.02% | 288 |
|
|
2026
Q1 | $1.56M | Sell |
3,174
-104
| -3% | -$56.4K | 0.02% | 275 |
|
|
2025
Q4 | $1.9M | Sell |
3,278
-1,269
| -28% | -$718K | 0.03% | 210 |
|
|
2025
Q3 | $2.21M | Sell |
4,547
-621
| -12% | -$289K | 0.04% | 188 |
|
|
2025
Q2 | $2.1M | Buy |
+5,168
| New | +$2.16M | 0.04% | 186 |
|
|
2024
Q3 | – | Sell |
-18,366
| Closed | -$10.2M | – | 1196 |
|
|
2024
Q2 | $10.2M | Buy |
18,366
+1,939
| +12% | +$1.11M | 0.23% | 127 |
|
|
2024
Q1 | $9.55M | Sell |
16,427
-7
| -0% | -$3.93K | 0.22% | 127 |
|
|
2023
Q4 | $8.72M | Buy |
16,434
+3,514
| +27% | +$1.7M | 0.21% | 128 |
|
|
2023
Q3 | $6.54M | Buy |
12,920
+1,018
| +9% | +$542K | 0.17% | 128 |
|
|
2023
Q2 | $6.21M | Buy |
11,902
+1,583
| +15% | +$854K | 0.16% | 130 |
|
|
2023
Q1 | $5.95M | Buy |
10,319
+2,328
| +29% | +$1.31M | 0.16% | 134 |
|
|
2022
Q4 | $4.4M | Sell |
7,991
-309
| -4% | -$164K | 0.14% | 142 |
|
|
2022
Q3 | $4.21M | Buy |
8,300
+625
| +8% | +$350K | 0.13% | 144 |
|
|
2022
Q2 | $4.17M | Sell |
7,675
-1,588
| -17% | -$874K | 0.12% | 148 |
|
|
2022
Q1 | $5.47M | Sell |
9,263
-7,072
| -43% | -$4.06M | 0.14% | 140 |
|
|
2021
Q4 | $10.9M | Buy |
16,335
+627
| +4% | +$391K | 0.28% | 108 |
|
|
2021
Q3 | $8.97M | Buy |
15,708
+92
| +0.6% | +$50.5K | 0.25% | 118 |
|
|
2021
Q2 | $7.88M | Buy |
15,616
+538
| +4% | +$254K | 0.23% | 119 |
|
|
2021
Q1 | $6.88M | Buy |
15,078
+2,868
| +23% | +$1.37M | 0.22% | 120 |
|
|
2020
Q4 | $5.39M | Sell |
12,210
-86
| -0.7% | -$40.3K | 0.23% | 96 |
|
|
2020
Q3 | $5.43M | Buy |
12,296
+1,015
| +9% | +$419K | 0.23% | 96 |
|
|
2020
Q2 | $4.09M | Buy |
11,281
+835
| +8% | +$280K | 0.19% | 117 |
|
|
2020
Q1 | $2.96M | Buy |
10,446
+2,148
| +26% | +$677K | 0.16% | 110 |
|
|
2019
Q4 | $2.7M | Buy |
8,298
+3,289
| +66% | +$997K | 0.12% | 117 |
|
|
2019
Q3 | $1.46M | Buy |
5,009
+1,107
| +28% | +$317K | 0.07% | 166 |
|
|
2019
Q2 | $1.15M | Buy |
3,902
+3,032
| +349% | +$835K | 0.06% | 178 |
|
|
2019
Q1 | $238K | Buy |
870
+711
| +447% | +$177K | 0.02% | 238 |
|
|
2018
Q4 | $36K | Buy |
159
+151
| +1,888% | +$35.4K | ﹤0.01% | 384 |
|
|
2018
Q3 | $2K | Hold |
8
| – | – | ﹤0.01% | 855 |
|
|
2018
Q2 | $2K | Sell |
8
-6
| -43% | -$1.27K | ﹤0.01% | 844 |
|
|
2018
Q1 | $3K | Sell |
14
-24
| -63% | -$5.04K | ﹤0.01% | 792 |
|
|
2017
Q4 | $7K | Buy |
+38
| New | +$7.28K | ﹤0.01% | 655 |
|
|
2017
Q3 | – | Sell |
-22
| Closed | -$4K | – | 666 |
|
|
2017
Q2 | $4K | Buy |
+22
| New | +$3.69K | ﹤0.01% | 624 |
|
|
2015
Q2 | – | Sell |
-40
| Closed | -$5K | – | 718 |
|
|
2015
Q1 | $5K | Buy |
+40
| New | +$5.16K | ﹤0.01% | 485 |
|
|
2013
Q3 | – | Sell |
-250
| Closed | -$21K | – | 589 |
|
|
2013
Q2 | $21K | Buy |
+250
| New | +$20.8K | 0.01% | 221 |
|
Other funds holding TMO
Gradient Investments's TMO Position: Q2 2026 in Review
Gradient Investments reduced its Thermo Fisher Scientific (TMO) stake by 0.44% in Q2 2026, selling an estimated $6.72K and leaving 3,160 shares worth $1.58M. The position accounts for 0.02% of the portfolio, ranked #288.
Gradient Investments first reported a position in TMO in Q2 2013 and has held it in 35 quarters since. The position peaked at $10.9M in Q4 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Gradient Investments held 3,160 shares of Thermo Fisher Scientific worth $1.58M as of Q2 2026.
- Gradient Investments sold 14 Thermo Fisher Scientific shares in Q2 2026, an estimated $6.72K.
- Thermo Fisher Scientific made up 0.02% of Gradient Investments's portfolio in Q2 2026, its #288 holding.
- Gradient Investments first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 35 quarters since.
- Gradient Investments's Thermo Fisher Scientific position peaked at $10.9M in Q4 2021.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Gradient Investments's 13F filing for Q2 2026, filed 8 Jul 2026.